These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6388363)
21. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Skodol AE; Gunderson JG; McGlashan TH; Dyck IR; Stout RL; Bender DS; Grilo CM; Shea MT; Zanarini MC; Morey LC; Sanislow CA; Oldham JM Am J Psychiatry; 2002 Feb; 159(2):276-83. PubMed ID: 11823271 [TBL] [Abstract][Full Text] [Related]
22. A comparison of thiothixene with chlorpromazine in the treatment of mania. Janicak PG; Bresnahan DB; Sharma R; Davis JM; Comaty JE; Malinick C J Clin Psychopharmacol; 1988 Feb; 8(1):33-7. PubMed ID: 3280617 [TBL] [Abstract][Full Text] [Related]
23. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Markovitz PJ; Calabrese JR; Schulz SC; Meltzer HY Am J Psychiatry; 1991 Aug; 148(8):1064-7. PubMed ID: 1853957 [TBL] [Abstract][Full Text] [Related]
24. Schizotypal symptoms in patients with borderline personality disorders. George A; Soloff PH Am J Psychiatry; 1986 Feb; 143(2):212-5. PubMed ID: 3946657 [TBL] [Abstract][Full Text] [Related]
25. Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG. Itil TM; Patterson CD; Keskiner A; Holden JM Adv Biochem Psychopharmacol; 1974; 9(0):499-509. PubMed ID: 4599437 [No Abstract] [Full Text] [Related]
26. The significance of borderline and schizotypal overlap. Plakun EM; Muller JP; Burkhardt PE Hillside J Clin Psychiatry; 1987; 9(1):47-54. PubMed ID: 3653842 [TBL] [Abstract][Full Text] [Related]
27. Drug treatment of the personality disorders. Stein G Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689 [TBL] [Abstract][Full Text] [Related]
34. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Sarai K; Okada M Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680 [TBL] [Abstract][Full Text] [Related]
36. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486 [TBL] [Abstract][Full Text] [Related]
38. Cognitive and perceptual distortions in borderline personality disorder and schizotypal personality disorder in a vignette sample. Sternbach SE; Judd PH; Sabo AN; McGlashan T; Gunderson JG Compr Psychiatry; 1992; 33(3):186-9. PubMed ID: 1591910 [TBL] [Abstract][Full Text] [Related]
39. Familial transmission of schizotypal and borderline personality disorders. Baron M; Gruen R; Asnis L; Lord S Am J Psychiatry; 1985 Aug; 142(8):927-34. PubMed ID: 4025588 [TBL] [Abstract][Full Text] [Related]
40. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia. Knight RG; Harrison A N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]